Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NHTC – Natural Health Trends Corp.

Float Short %

0.63

Margin Of Safety %

Put/Call OI Ratio

1.15

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

3.37

Target Price

Analyst Recom

Performance Q

5.4

Upside

-131.3%

Beta

0.81

Ticker: NHTC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23NHTC3.831.110.00438
2026-01-26NHTC3.851.070.00445
2026-01-27NHTC3.731.070.00445
2026-01-28NHTC3.711.070.00445
2026-01-29NHTC3.661.070.71445
2026-01-30NHTC3.841.070.71445
2026-02-02NHTC3.791.070.71445
2026-02-03NHTC3.81.130.00443
2026-02-04NHTC41.12999.99445
2026-02-05NHTC3.71.12999.99445
2026-02-06NHTC3.911.120.00445
2026-02-09NHTC3.811.120.00445
2026-02-10NHTC3.821.040.00462
2026-02-11NHTC3.661.040.00462
2026-02-12NHTC3.710.98999.99474
2026-02-13NHTC3.720.980.00474
2026-02-17NHTC3.341.09999.99451
2026-02-18NHTC3.331.13999.99461
2026-02-20NHTC3.371.15999.99464
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23NHTC3.80- - -
2026-01-26NHTC3.81- - -
2026-01-27NHTC3.72- - -
2026-01-28NHTC3.75- - -
2026-01-29NHTC3.73- - -
2026-01-30NHTC3.82- - -
2026-02-02NHTC3.82- - -
2026-02-03NHTC3.83- - -
2026-02-04NHTC3.96- - -
2026-02-05NHTC3.70- - -
2026-02-06NHTC3.84- - -
2026-02-09NHTC3.81- - -
2026-02-10NHTC3.76- - -
2026-02-11NHTC3.65- - -
2026-02-12NHTC3.71- - -
2026-02-13NHTC3.71- - -
2026-02-17NHTC3.33- - -
2026-02-18NHTC3.26- - -
2026-02-19NHTC3.30- - -
2026-02-20NHTC3.37- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23NHTC0.00-17.510.47
2026-01-26NHTC0.00-17.510.47
2026-01-27NHTC0.00-17.510.47
2026-01-28NHTC0.00-17.510.58
2026-01-29NHTC0.00-17.510.58
2026-01-30NHTC0.00-17.510.58
2026-02-02NHTC0.00-17.510.58
2026-02-03NHTC0.00-17.510.58
2026-02-04NHTC0.00-17.510.58
2026-02-05NHTC0.00-17.510.58
2026-02-06NHTC0.00-17.510.58
2026-02-10NHTC0.00-16.350.58
2026-02-11NHTC0.00-16.350.63
2026-02-12NHTC0.00-16.350.63
2026-02-13NHTC0.00-16.350.63
2026-02-17NHTC0.00-20.030.63
2026-02-18NHTC0.00-20.030.63
2026-02-19NHTC0.00-20.030.63
2026-02-20NHTC0.00-20.030.63
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-20.03

Beta

0.81

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

48

Growth Score

26

Sentiment Score

37

Actual DrawDown %

59.2

Max Drawdown 5-Year %

-60.2

Target Price

P/E

Forward P/E

PEG

P/S

0.96

P/B

1.46

P/Free Cash Flow

EPS

-0.08

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2.22

Relative Volume

0.43

Return on Equity vs Sector %

-17.3

Return on Equity vs Industry %

-19

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Natural Health Trends Corp. - C
Sector: Consumer Cyclical
Industry: Internet Retail
Employees:
Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, such as liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, and minerals; and herbal products, including herbal supplements. It also provides beauty products comprising age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products consisting of weight management and energy enhancing supplements, as well as topical gels. In addition, the company offers home appliances; daily products, such as oral, hair, and body care products; and at-home testing kits for measuring critical biomarkers of well-being, including cardiovascular, hormonal, inflammatory, metabolic, and nutritional health. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, the Cayman Islands, Mexico, Peru, and Colombia; Hong Kong, Taiwan, and China; Malaysia and Singapore; South Korea; Russia and Kazakhstan; Japan; India; and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Rolling Hills Estates, California.
stock quote shares NHTC – Natural Health Trends Corp. Stock Price stock today
news today NHTC – Natural Health Trends Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch NHTC – Natural Health Trends Corp. yahoo finance google finance
stock history NHTC – Natural Health Trends Corp. invest stock market
stock prices NHTC premarket after hours
ticker NHTC fair value insiders trading

MSC – Studio City International Holdings Ltd ADR

Float Short %

0.01

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.93

Target Price

11

Analyst Recom

1

Performance Q

-25.32

Upside

-238.0%

Beta

-0.05

Ticker: MSC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23MSC3.24N/AN/A0
2026-01-26MSC3.25N/AN/A0
2026-01-27MSC3.24N/AN/A0
2026-01-28MSC3.18N/AN/A0
2026-01-29MSC3.04N/AN/A0
2026-01-30MSC3.09N/AN/A0
2026-02-02MSC3N/AN/A0
2026-02-03MSC2.99N/AN/A0
2026-02-04MSC3.01N/AN/A0
2026-02-05MSC3.01N/AN/A0
2026-02-06MSC3.195N/AN/A0
2026-02-09MSC3.19N/AN/A0
2026-02-10MSC3.29N/AN/A0
2026-02-11MSC3.28N/AN/A0
2026-02-12MSC3.3N/AN/A0
2026-02-13MSC3.01N/AN/A0
2026-02-17MSC3.01N/AN/A0
2026-02-18MSC3.01N/AN/A0
2026-02-20MSC2.93N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23MSC3.32- - -
2026-01-26MSC3.59- - -
2026-01-27MSC3.24- - -
2026-01-28MSC3.18- - -
2026-01-29MSC3.04- - -
2026-01-30MSC3.09- - -
2026-02-02MSC3.12- - -
2026-02-03MSC3.12- - -
2026-02-04MSC3.12- - -
2026-02-05MSC3.21- - -
2026-02-06MSC3.01- - -
2026-02-09MSC3.02- - -
2026-02-10MSC3.02- - -
2026-02-11MSC3.19- - -
2026-02-12MSC3.19- - -
2026-02-13MSC3.01- - -
2026-02-17MSC3.01- - -
2026-02-18MSC3.01- - -
2026-02-19MSC2.92- - -
2026-02-20MSC2.93- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23MSC0-7.660.01
2026-01-26MSC0-7.660.01
2026-01-27MSC0-7.660.01
2026-01-28MSC0-7.660.01
2026-01-29MSC0-7.660.01
2026-01-30MSC0-7.660.01
2026-02-02MSC0-7.660.01
2026-02-03MSC0-7.660.01
2026-02-04MSC0-7.660.01
2026-02-05MSC0-7.660.01
2026-02-06MSC0-7.660.01
2026-02-10MSC0-7.650.01
2026-02-11MSC0-7.650.01
2026-02-12MSC0-7.650.01
2026-02-13MSC0-7.650.01
2026-02-17MSC0-0.040.01
2026-02-18MSC0-0.040.01
2026-02-19MSC0-0.040.01
2026-02-20MSC0-0.040.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.04

Beta

-0.05

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

50

Growth Score

60

Sentiment Score

5

Actual DrawDown %

81.7

Max Drawdown 5-Year %

-90.3

Target Price

11

P/E

Forward P/E

PEG

P/S

0.81

P/B

1.17

P/Free Cash Flow

EPS

-0.31

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.46

Relative Volume

0.41

Return on Equity vs Sector %

-27.9

Return on Equity vs Industry %

-40.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Studio City International Holdi
Sector: Consumer Cyclical
Industry: Resorts & Casinos
Employees:
Studio City International Holdings Limited provides provision of services pursuant to a casino contract and the hospitality business in Macau. It operates Studio City Casino, comprising gaming tables, including tables for VIP rolling chip operations and gaming machines; and resort, which offers various non-gaming attractions, including figure-8 ferris wheel, night club and karaoke venue, live performance arena, and an outdoor and indoor water park, as well as live performance arena and various food and beverage establishments, and retail space. The company was formerly known as Cyber One Agents Limited and changed its name to Studio City International Holdings Limited in January 2012. The company was founded in 2000 and is based in Central, Hong Kong. Studio City International Holdings Limited is a subsidiary of MCO Cotai Investments Limited.
stock quote shares MSC – Studio City International Holdings Ltd ADR Stock Price stock today
news today MSC – Studio City International Holdings Ltd ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch MSC – Studio City International Holdings Ltd ADR yahoo finance google finance
stock history MSC – Studio City International Holdings Ltd ADR invest stock market
stock prices MSC premarket after hours
ticker MSC fair value insiders trading

FUTU – Futu Holdings Limited

Float Short %

4.24

Margin Of Safety %

Put/Call OI Ratio

1.27

EPS Next Q Diff

EPS Last/This Y

72.96

EPS This/Next Y

11.57

Price

155.36

Target Price

233.65

Analyst Recom

1.1

Performance Q

-7.37

Upside

101.6%

Beta

0.37

Ticker: FUTU




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23FUTU161.661.471.1974309
2026-01-26FUTU162.981.580.5173736
2026-01-27FUTU163.011.550.6675221
2026-01-28FUTU168.351.560.2576696
2026-01-29FUTU164.871.500.7678043
2026-01-30FUTU162.561.490.7778104
2026-02-02FUTU161.721.540.9374314
2026-02-03FUTU159.791.541.5875443
2026-02-04FUTU153.411.541.3976605
2026-02-05FUTU149.911.521.5578719
2026-02-06FUTU151.591.501.0679626
2026-02-09FUTU156.331.530.4077544
2026-02-10FUTU158.51.480.5778933
2026-02-11FUTU154.761.461.0179865
2026-02-12FUTU147.521.461.6580176
2026-02-13FUTU146.821.400.6980271
2026-02-17FUTU148.971.430.5475365
2026-02-18FUTU152.41.350.4976202
2026-02-20FUTU155.321.271.0678454
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23FUTU161.6176.7- 78.02
2026-01-26FUTU163.0676.7- 78.02
2026-01-27FUTU163.0676.7- 78.02
2026-01-28FUTU168.3476.7- 78.02
2026-01-29FUTU164.9476.7- 78.02
2026-01-30FUTU162.6170.8- 78.02
2026-02-02FUTU161.7170.8- 78.02
2026-02-03FUTU159.8470.8- 78.02
2026-02-04FUTU153.3870.8- 78.02
2026-02-05FUTU149.9170.8- 78.02
2026-02-06FUTU151.5670.8- 78.02
2026-02-09FUTU156.2570.8- 78.02
2026-02-10FUTU158.3570.8- 78.02
2026-02-11FUTU154.7770.8- 78.02
2026-02-12FUTU147.4670.8- 78.02
2026-02-13FUTU146.8870.8- 78.02
2026-02-17FUTU149.0570.8- 78.02
2026-02-18FUTU152.5070.8- 78.02
2026-02-19FUTU153.5270.8- 78.02
2026-02-20FUTU155.3670.8- 78.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23FUTU0.0014.115.17
2026-01-26FUTU0.0013.935.17
2026-01-27FUTU0.0013.935.17
2026-01-28FUTU0.0013.935.80
2026-01-29FUTU0.0013.935.80
2026-01-30FUTU0.0013.935.80
2026-02-02FUTU0.0013.085.80
2026-02-03FUTU0.0013.085.80
2026-02-04FUTU0.0013.085.80
2026-02-05FUTU0.0013.085.79
2026-02-06FUTU0.0013.085.79
2026-02-09FUTU0.009.345.79
2026-02-10FUTU0.009.345.79
2026-02-11FUTU0.009.344.24
2026-02-12FUTU0.009.344.24
2026-02-13FUTU0.009.344.24
2026-02-17FUTU0.0010.784.24
2026-02-18FUTU0.0010.784.24
2026-02-19FUTU0.0010.784.24
2026-02-20FUTU0.0010.784.24
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

24.61

Avg. EPS Est. Next Quarter

26.71

Insider Transactions

Institutional Transactions

10.78

Beta

0.37

Average Sales Estimate Current Quarter

5664

Average Sales Estimate Next Quarter

6223

Fair Value

Quality Score

85

Growth Score

100

Sentiment Score

94

Actual DrawDown %

23.3

Max Drawdown 5-Year %

-87.1

Target Price

233.65

P/E

17.36

Forward P/E

14.63

PEG

0.46

P/S

5.49

P/B

4.61

P/Free Cash Flow

EPS

8.95

Average EPS Est. Cur. Y​

78.02

EPS Next Y. (Est.)

89.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

47.11

Relative Volume

0.83

Return on Equity vs Sector %

15.4

Return on Equity vs Industry %

13.4

EPS 1 7Days Diff

8.4

EPS 1 30Days Diff

10.87

EBIT Estimation

Futu Holdings Limited
Sector: Financial Services
Industry: Capital Markets
Employees: 3343
Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. The company offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. It also provides financial information and online community services; online wealth management services under the Money Plus brand name through its Futubull and moomoo platforms, which provides its client access to mutual funds, private funds, bonds, structured products, and other wealth management products; market data and information services; and NiuNiu Community, an open forum for users and clients to share insights, ask questions, and exchange ideas. Futu Holdings Limited was founded in 2007 and is headquartered in Admiralty, Hong Kong.
stock quote shares FUTU – Futu Holdings Limited Stock Price stock today
news today FUTU – Futu Holdings Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch FUTU – Futu Holdings Limited yahoo finance google finance
stock history FUTU – Futu Holdings Limited invest stock market
stock prices FUTU premarket after hours
ticker FUTU fair value insiders trading

HCM – HUTCHMED (China) Limited

Float Short %

0.19

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

EPS Last/This Y

1.25

EPS This/Next Y

-1.06

Price

15.27

Target Price

24.31

Analyst Recom

1.5

Performance Q

4.3

Upside

127.9%

Beta

0.43

Ticker: HCM




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23HCM15.420.464.00315
2026-01-26HCM15.530.464.00315
2026-01-27HCM15.260.464.00315
2026-01-28HCM15.150.470.00320
2026-01-29HCM15.250.470.00320
2026-01-30HCM14.980.460.00325
2026-02-02HCM14.410.462.50328
2026-02-03HCM14.480.462.50328
2026-02-04HCM14.780.50999.99338
2026-02-05HCM14.590.550.00348
2026-02-06HCM15.170.540.00351
2026-02-09HCM14.920.540.00351
2026-02-10HCM14.840.540.00351
2026-02-11HCM15.10.540.00351
2026-02-12HCM14.730.540.00351
2026-02-13HCM14.770.550.00346
2026-02-17HCM15.020.550.00346
2026-02-18HCM15.110.550.00346
2026-02-19HCM15.04N/AN/A0
2026-02-20HCM15.270.550.00346
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23HCM15.36- -67.01.45
2026-01-26HCM15.54- -69.41.45
2026-01-27HCM15.27- -67.41.45
2026-01-28HCM15.25- -68.71.45
2026-01-29HCM15.31- -69.01.45
2026-01-30HCM14.92- -68.61.45
2026-02-02HCM14.48- -65.21.45
2026-02-03HCM14.44- -66.81.45
2026-02-04HCM14.74- -68.51.45
2026-02-05HCM14.59- -66.41.45
2026-02-06HCM15.15- -70.71.45
2026-02-09HCM14.92- -73.41.45
2026-02-10HCM14.90- -67.71.45
2026-02-11HCM15.10- -65.81.45
2026-02-12HCM14.61- -67.31.45
2026-02-13HCM14.84- -70.71.45
2026-02-17HCM15.18- -71.41.45
2026-02-18HCM15.16- -72.41.45
2026-02-19HCM15.02- - 1.45
2026-02-20HCM15.27- - 1.45
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23HCM0.000.650.22
2026-01-26HCM0.000.530.22
2026-01-27HCM0.000.530.22
2026-01-28HCM0.000.530.20
2026-01-29HCM0.000.530.20
2026-01-30HCM0.000.530.20
2026-02-02HCM0.000.520.20
2026-02-03HCM0.000.520.20
2026-02-04HCM0.000.520.20
2026-02-05HCM0.000.520.20
2026-02-06HCM0.000.520.20
2026-02-09HCM0.000.700.20
2026-02-10HCM0.000.700.20
2026-02-11HCM0.000.700.19
2026-02-12HCM0.000.700.19
2026-02-13HCM0.000.700.19
2026-02-17HCM0.00-2.420.19
2026-02-18HCM0.00-2.420.19
2026-02-19HCM0.00-2.420.19
2026-02-20HCM0.00-2.420.19
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-2.42

Beta

0.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

87

Growth Score

60

Sentiment Score

65

Actual DrawDown %

65.3

Max Drawdown 5-Year %

-82.2

Target Price

24.31

P/E

5.7

Forward P/E

73.78

PEG

2.18

P/S

4.42

P/B

2.17

P/Free Cash Flow

EPS

2.68

Average EPS Est. Cur. Y​

1.45

EPS Next Y. (Est.)

0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

77.54

Relative Volume

0.18

Return on Equity vs Sector %

9

Return on Equity vs Industry %

30.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

HUTCHMED (China) Limited
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1780
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
stock quote shares HCM – HUTCHMED (China) Limited Stock Price stock today
news today HCM – HUTCHMED (China) Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch HCM – HUTCHMED (China) Limited yahoo finance google finance
stock history HCM – HUTCHMED (China) Limited invest stock market
stock prices HCM premarket after hours
ticker HCM fair value insiders trading

MLCO – Melco Resorts & Entertainment Limited

Float Short %

1.56

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.23

Price

6.07

Target Price

9.62

Analyst Recom

1.71

Performance Q

-32.67

Upside

165.7%

Beta

0.58

Ticker: MLCO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23MLCO6.360.551.6922878
2026-01-26MLCO6.430.550.2221854
2026-01-27MLCO6.280.530.2922427
2026-01-28MLCO6.260.510.3422759
2026-01-29MLCO6.050.512.3322897
2026-01-30MLCO6.050.530.0723195
2026-02-02MLCO6.240.550.6422142
2026-02-03MLCO6.080.560.5222386
2026-02-04MLCO6.180.560.0522391
2026-02-05MLCO6.070.551.6822492
2026-02-06MLCO6.350.550.0923564
2026-02-09MLCO6.410.600.1922308
2026-02-10MLCO6.30.590.4322961
2026-02-11MLCO6.150.590.6723390
2026-02-12MLCO5.370.600.6623707
2026-02-13MLCO5.510.590.0424131
2026-02-17MLCO5.60.600.4423958
2026-02-18MLCO5.630.603.4924416
2026-02-19MLCO5.880.600.1124453
2026-02-20MLCO6.070.451.0530104
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23MLCO6.351500.0122.20.56
2026-01-26MLCO6.431500.0124.40.56
2026-01-27MLCO6.271500.0117.70.56
2026-01-28MLCO6.261500.0121.40.56
2026-01-29MLCO6.061500.0115.70.56
2026-01-30MLCO6.051500.0122.10.56
2026-02-02MLCO6.231500.0127.20.56
2026-02-03MLCO6.081500.0117.00.56
2026-02-04MLCO6.181500.0125.50.56
2026-02-05MLCO6.061500.0118.60.56
2026-02-06MLCO6.341500.0130.70.56
2026-02-09MLCO6.421500.0124.40.56
2026-02-10MLCO6.301500.0118.90.56
2026-02-11MLCO6.151500.0117.40.56
2026-02-12MLCO5.381500.098.10.56
2026-02-13MLCO5.501500.0125.40.56
2026-02-17MLCO5.60- 124.80.56
2026-02-18MLCO5.63- 122.20.56
2026-02-19MLCO5.88- 129.80.56
2026-02-20MLCO6.07- - 0.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23MLCO0.00-6.051.75
2026-01-26MLCO0.00-6.051.75
2026-01-27MLCO0.00-6.051.75
2026-01-28MLCO0.00-6.051.78
2026-01-29MLCO0.00-6.051.78
2026-01-30MLCO0.00-6.051.78
2026-02-02MLCO0.00-6.121.78
2026-02-03MLCO0.00-6.121.78
2026-02-04MLCO0.00-6.121.78
2026-02-05MLCO0.00-6.121.78
2026-02-06MLCO0.00-6.121.78
2026-02-09MLCO0.00-3.371.78
2026-02-10MLCO0.00-3.371.78
2026-02-11MLCO0.00-3.371.56
2026-02-12MLCO0.00-3.371.56
2026-02-13MLCO0.00-3.371.56
2026-02-17MLCO0.00-1.881.56
2026-02-18MLCO0.00-1.881.56
2026-02-19MLCO0.00-1.881.56
2026-02-20MLCO0.00-1.881.56
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.08

Avg. EPS Est. Next Quarter

0.15

Insider Transactions

Institutional Transactions

-1.88

Beta

0.58

Average Sales Estimate Current Quarter

1321

Average Sales Estimate Next Quarter

1378

Fair Value

Quality Score

54

Growth Score

67

Sentiment Score

92

Actual DrawDown %

74.3

Max Drawdown 5-Year %

-80.8

Target Price

9.62

P/E

13.04

Forward P/E

7.76

PEG

0.33

P/S

0.46

P/B

P/Free Cash Flow

EPS

0.46

Average EPS Est. Cur. Y​

0.56

EPS Next Y. (Est.)

0.8

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

3.58

Relative Volume

1.67

Return on Equity vs Sector %

-24.8

Return on Equity vs Industry %

-37.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.12

EBIT Estimation

Melco Resorts & Entertainment L
Sector: Consumer Cyclical
Industry: Resorts & Casinos
Employees:
Melco Resorts & Entertainment Limited develops, owns, and operates casino gaming and resort facilities in Asia and Europe. It owns and operates City of Dreams, an integrated casino resort that has gaming tables and gaming machines; suites and villas; restaurants and bars; retail outlets; a wet stage performance theater; and recreation and leisure facilities. The company also operates Altira Macau, a casino hotel, which has gaming tables and gaming machines; hotel rooms; dining and casual restaurants; recreation and leisure facilities; and non-gaming amenities. In addition, it operates Studio City, a cinematically themed integrated resort with gaming facilities, hotel, entertainment, retail, and food and beverage outlets in Cotai, Macau. Further, the company owns and operates Mocha Clubs with gaming machines, as well as Grand Dragon casino in Taipa Island, Macau. Additionally, it operates and manages City of Dreams Manila, an integrated resort in the Entertainment City complex in Manila; a casino in Limassol and satellite casinos in Nicosia, Ayia Napa, and Paphos in Cyprus; and develops and operates City of Dreams Mediterranean, an integrated casino resort in Cyprus. The company was formerly known as Melco Crown Entertainment Limited and changed its name to Melco Resorts & Entertainment Limited in April 2017. Melco Resorts & Entertainment Limited was incorporated in 2004 and is based in Central, Hong Kong. The company operates as a subsidiary of Melco Leisure and Entertainment Group Limited.
stock quote shares MLCO – Melco Resorts & Entertainment Limited Stock Price stock today
news today MLCO – Melco Resorts & Entertainment Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch MLCO – Melco Resorts & Entertainment Limited yahoo finance google finance
stock history MLCO – Melco Resorts & Entertainment Limited invest stock market
stock prices MLCO premarket after hours
ticker MLCO fair value insiders trading

CO – Global Cord Blood Corporation

Float Short %

0.35

Margin Of Safety %

35

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.99

Target Price

Analyst Recom

Performance Q

Upside

N/A

Beta

0.17

Ticker: CO




17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23CO2.9876N/AN/A0
2026-01-26CO2.9876N/AN/A0
2026-01-27CO2.9876N/AN/A0
2026-01-28CO2.9876N/AN/A0
2026-01-29CO2.9876N/AN/A0
2026-01-30CO2.9876N/AN/A0
2026-02-02CO2.9876N/AN/A0
2026-02-04CO2.9876N/AN/A0
2026-02-05CO2.9876N/AN/A0
2026-02-06CO2.9876N/AN/A0
2026-02-09CO2.9876N/AN/A0
2026-02-10CO2.9876N/AN/A0
2026-02-11CO2.9876N/AN/A0
2026-02-12CO2.9876N/AN/A0
2026-02-13CO2.9876N/AN/A0
2026-02-18CO2.9876N/AN/A0
2026-02-19CO2.9876N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1




No data found




No data found

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.15

Beta

0.17

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

4.03

Quality Score

86

Growth Score

71

Sentiment Score

58

Actual DrawDown %

70.5

Max Drawdown 5-Year %

-79.7

Target Price

P/E

5.03

Forward P/E

PEG

0.17

P/S

1.66

P/B

0.51

P/Free Cash Flow

3.36

EPS

0.58

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

40.3

Relative Volume

Return on Equity vs Sector %

-11.9

Return on Equity vs Industry %

-2.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

stock quote shares CO – Global Cord Blood Corporation Stock Price stock today
news today CO – Global Cord Blood Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CO – Global Cord Blood Corporation yahoo finance google finance
stock history CO – Global Cord Blood Corporation invest stock market
stock prices CO premarket after hours
ticker CO fair value insiders trading